These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27975170)

  • 21. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease.
    Maswood N; Young J; Tilmont E; Zhang Z; Gash DM; Gerhardt GA; Grondin R; Roth GS; Mattison J; Lane MA; Carson RE; Cohen RM; Mouton PR; Quigley C; Mattson MP; Ingram DK
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18171-6. PubMed ID: 15604149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.
    Karuppagounder SS; Brahmachari S; Lee Y; Dawson VL; Dawson TM; Ko HS
    Sci Rep; 2014 May; 4():4874. PubMed ID: 24786396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease.
    Srivastava P; Nishiyama S; Zhou F; Lin SH; Srivastava A; Su C; Xu Y; Peng W; Levy M; Schwarzschild M; Chen X
    J Neuroimmune Pharmacol; 2023 Dec; 18(4):704-717. PubMed ID: 38110615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current disease modifying approaches to treat Parkinson's disease.
    Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
    Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Liver Growth Factor (LGF) in Parkinson's Disease: Molecular Insights and Therapeutic Opportunities.
    Angelopoulou E; Paudel YN; Piperi C
    Mol Neurobiol; 2021 Jul; 58(7):3031-3042. PubMed ID: 33608826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.
    De Jesús-Cortés H; Xu P; Drawbridge J; Estill SJ; Huntington P; Tran S; Britt J; Tesla R; Morlock L; Naidoo J; Melito LM; Wang G; Williams NS; Ready JM; McKnight SL; Pieper AA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17010-5. PubMed ID: 23027934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice.
    Ramírez-Carreto RJ; Zaldívar-Machorro VJ; Pérez-Ramírez DJ; Rodríguez-López BE; Meza C; García E; Santamaría A; Chavarría A
    Mol Neurobiol; 2023 Dec; 60(12):6774-6788. PubMed ID: 37480498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review.
    Hassani S; Esmaeili A
    Ageing Res Rev; 2024 Jun; 97():102299. PubMed ID: 38604452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
    Ahuja M; Ammal Kaidery N; Attucks OC; McDade E; Hushpulian DM; Gaisin A; Gaisina I; Ahn YH; Nikulin S; Poloznikov A; Gazaryan I; Yamamoto M; Matsumoto M; Igarashi K; Sharma SM; Thomas B
    Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34737234
    [No Abstract]   [Full Text] [Related]  

  • 30. Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K / AKT Pathway in Parkinson's Disease.
    Cai B; Wang Q; Zhong L; Liu F; Wang X; Chen T
    Drug Des Devel Ther; 2024; 18():2869-2881. PubMed ID: 39006191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease.
    O'Neill MJ; Murray TK; Clay MP; Lindstrom T; Yang CR; Nisenbaum ES
    CNS Drug Rev; 2005; 11(1):77-96. PubMed ID: 15867954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview.
    Zhang N; Guo P; Zhao Y; Qiu X; Shao S; Liu Z; Gao Z
    Biomed Pharmacother; 2024 Aug; 177():117101. PubMed ID: 39002442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Mouse Model of Nigrostriatal Dopaminergic Axonal Degeneration As a Tool for Testing Neuroprotectors.
    Kolacheva AA; Ugrumov MV
    Acta Naturae; 2021; 13(3):110-113. PubMed ID: 34707903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duality of Antidepressants and Neuroprotectants.
    Tizabi Y
    Neurotox Res; 2016 Jul; 30(1):1-13. PubMed ID: 26613895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine restores olfactory function by activation of prok2R/Akt/FoxO3a axis in Parkinson's disease.
    Guo Q; Wang Y; Yu L; Guan L; Ji X; Li X; Pang G; Ren Z; Ye L; Cheng H
    J Transl Med; 2024 Apr; 22(1):350. PubMed ID: 38609979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease.
    Eo H; Yu SH; Choi Y; Kim Y; Kang YC; Lee H; Kim JH; Han K; Lee HK; Chang MY; Oh MS; Kim CH
    Neurotherapeutics; 2024 Apr; 21(4):e00355. PubMed ID: 38580511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional modification of recombinant brain-derived neurotrophic factor and its protective effect against neurotoxicity.
    Liu C; Yan Q; Ding X; Zhao M; Chen C; Zheng Q; Yang H; Xie Y
    Int J Biol Macromol; 2024 May; 267(Pt 2):131610. PubMed ID: 38621565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SYNJ1 rescues motor functions in hereditary and sporadic Parkinson's disease mice by upregulating TSP-1 expression.
    Tian Y; Yi S; Guo W; Feng C; Zhang X; Dong H; Wang K; Li R; Tian Y; Gan M; Wu T; Xie H; Gao X
    Behav Brain Res; 2023 Aug; 452():114569. PubMed ID: 37419331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Approaches and Tools Used in Drug Development against Parkinson's Disease.
    Koszła O; Stępnicki P; Zięba A; Grudzińska A; Matosiuk D; Kaczor AA
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astrocytes and therapeutics for Parkinson's disease.
    Rappold PM; Tieu K
    Neurotherapeutics; 2010 Oct; 7(4):413-23. PubMed ID: 20880505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.